DOI:
10.1055/s-00033990
TH Open
LinksClose Window
References
Callewaert F, Roodt J, Ulrichts H. , et al.
Evaluation of efficacy and safety of the anti-VWF Nanobody ALX-0681 in a preclinical baboon model of acquired thrombotic thrombocytopenic purpura.
Blood 2012;
120 (17) 3603-3610
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.